Eli Lilly (LLY.N) fell 2.6 percent as it forecast weak fourth-quarter sales of its diet pills.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights